Pharmacodynamics and Tolerance of Nicotinamide Mononucleotide (NMN, 400mg/Day) in Healthy Adults
NCT04862338
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
17
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DIETARY_SUPPLEMENT:
Nicotinamide mononucleotide (NMN-C)
Sponsor
Seneque SA
Collaborators
[object Object]
[object Object]